Literature DB >> 29185857

Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine.

Catharine I Paules1, Sheena G Sullivan1, Kanta Subbarao1, Anthony S Fauci1.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29185857     DOI: 10.1056/NEJMp1714916

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  92 in total

1.  Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.

Authors:  Yao-Qing Chen; Linda Yu-Ling Lan; Min Huang; Carole Henry; Patrick C Wilson
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity.

Authors:  Ji Wang; Peiyu Li; Yang Yu; Yuhong Fu; Hongye Jiang; Min Lu; Zhiping Sun; Shibo Jiang; Lu Lu; Mei X Wu
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

3.  Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.

Authors:  Florian Krammer; Peter Palese
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

4.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

5.  Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.

Authors:  Joshua G Petrie; Emily T Martin; Rachel Truscon; Emileigh Johnson; Caroline K Cheng; E J McSpadden; Ryan E Malosh; Adam S Lauring; Lois E Lamerato; Maryna C Eichelberger; Jill M Ferdinands; Arnold S Monto
Journal:  Vaccine       Date:  2019-02-07       Impact factor: 3.641

6.  Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18.

Authors:  E Pawelka; Mario Karolyi; S Daller; C Kaczmarek; H Laferl; I Niculescu; B Schrader; C Stütz; A Zoufaly; C Wenisch
Journal:  Infection       Date:  2019-06-15       Impact factor: 3.553

7.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Authors:  Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

8.  Optimizing the impact of low-efficacy influenza vaccines.

Authors:  Pratha Sah; Jan Medlock; Meagan C Fitzpatrick; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

9.  Simplified steps to heterologous prime-boost HIV vaccine development?

Authors:  Nelson L Michael
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

10.  Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine.

Authors:  Alberto Pérez-Rubio; Julio Ancochea; Jose María Eiros Bouza
Journal:  Hum Vaccin Immunother       Date:  2020-04-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.